Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs NTAP✓SelectedUSD · NTAPMRNA vs NTAP performance historyLatest closeAs of+1.29%11/19
Stock and ETF performance explorer

MRNA vs NTAP

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+791.5%
NTAP return
+59.5%
Excess return
+731.9%
Maximum drawdown
-34.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioNTAPExcessAlpha
1D+1.3%-1.2%+2.5%+1.0%
7D-13.8%-8.5%-5.3%-15.5%
30D-17.7%-19.0%+1.3%-21.9%
3M+14.3%-12.3%+26.6%+11.7%
6M+336.0%+41.9%+294.1%+289.1%
YTD+575.9%+61.4%+514.6%+461.2%
All+791.5%+59.5%+731.9%+631.0%

Cumulative growth

Daily Returns

Daily percentage return beside NTAP.

Daily Out/Under-Performance

Portfolio return minus NTAP return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × NTAP return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded NTAP wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling